CARTEOL L.P. 2 % sans conservateur, eye drop solution with extended release bottle, 8 ml
Active ingredients: Carteolol hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solution with extended releasebottle, 8 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CARTEOL L.P. 2 % sans conservateur, collyre en solution à libération prolongée
- Pharmaceutical form
- collyre en solution à libération prolongée
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon compte-gouttes polyéthylène basse densité (PEBD) multidose(s) avec fermeture à témoin d'effraction de 8 mL
- Marketing authorisation holder
- LABORATOIRE CHAUVIN
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Jul 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66831579CIP73029242CIP133400930292426Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE CARTÉOLOLcollyre | 20 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.